Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
04/21/2022 | Outlook Therapeutics, Inc. | ONS | Other (disposition) | Common Stock | 28M | $0.00 | $0 | | 04/21/2022 |
03/23/2020 | Outlook Therapeutics, Inc. | ONS | Exercise | Series A-1 Convertible Preferred Stock | 68.1k | $0.00 | $0 | | 03/19/2020 |
03/19/2020 | Outlook Therapeutics, Inc. | ONS | Grant | Series A-1 Convertible Preferred Stock | 68.1k | $0.00 | $0 | | 03/19/2020 |
03/19/2020 | Outlook Therapeutics, Inc. | ONS | Disposition | Series A-1 Convertible Preferred Stock | 68.1k | $0.00 | $0 | | 03/19/2020 |
01/29/2020 | Outlook Therapeutics, Inc. | ONS | Exercise | Warrant (Right to Buy) | 2.1M | $0.23 | $485.8k | | 01/27/2020 |
01/29/2020 | Outlook Therapeutics, Inc. | ONS | Exercise | Warrant (Right to Buy) | 1.3M | $0.23 | $297.4k | | 01/27/2020 |
01/27/2020 | Outlook Therapeutics, Inc. | ONS | Disposition | Warrant (Right to Buy) | 2.1M | $0.00 | $0 | | 01/27/2020 |
01/27/2020 | Outlook Therapeutics, Inc. | ONS | Grant | Warrant (Right to Buy) | 2.1M | $0.23 | $485.8k | | 01/27/2020 |
01/27/2020 | Outlook Therapeutics, Inc. | ONS | Disposition | Warrant (Right to Buy) | 1.3M | $1.00 | $1.3M | | 01/27/2020 |
01/27/2020 | Outlook Therapeutics, Inc. | ONS | Grant | Warrant (Right to Buy) | 1.3M | $0.23 | $297.4k | | 01/27/2020 |
12/31/2019 | Outlook Therapeutics, Inc. | ONS | Other (acquisition) | Series A-1 Convertible Preferred Stock | 1.7k | $0.00 | $0 | | 12/31/2019 |
12/23/2019 | Outlook Therapeutics, Inc. | ONS | Exercise | Warrant (Right to Buy) | 3.6M | $0.23 | $843.6k | | 12/23/2019 |
09/30/2019 | Outlook Therapeutics, Inc. | ONS | Other (acquisition) | Series A-1 Convertible Preferred Stock | 1.6k | $0.00 | $0 | | 09/30/2019 |
06/30/2019 | Outlook Therapeutics, Inc. | ONS | Other (acquisition) | Series A-1 Convertible Preferred Stock | 1.6k | $0.00 | $0 | | 06/30/2019 |
06/17/2019 | Outlook Therapeutics, Inc. | ONS | Exercise | Warrant (Right to Buy) | 3.6M | $2.90 | $10.5M | | 06/17/2019 |
06/17/2019 | Outlook Therapeutics, Inc. | ONS | Exercise | Common Stock | 2.2M | $0.00 | $0 | | 06/17/2019 |
04/12/2019 | Outlook Therapeutics, Inc. | ONS | Grant | Common Stock | 3.6M | $2.75 | $10M | | 04/12/2019 |
04/12/2019 | Outlook Therapeutics, Inc. | ONS | Grant | Warrant (Right to Buy) | 3.6M | $2.90 | $10.5M | | 04/12/2019 |
03/31/2019 | Outlook Therapeutics, Inc. | ONS | Other (acquisition) | Series A-1 Convertible Preferred Stock | 1.5k | $0.00 | $0 | | 03/31/2019 |
02/01/2019 | Outlook Therapeutics, Inc. | ONS | Grant | Common Stock | 4.3M | $0.93 | $4M | | 02/01/2019 |
01/02/2019 | Outlook Therapeutics, Inc. | ONS | Grant | Common Stock | 4.3M | $0.93 | $4M | | 01/02/2019 |
12/31/2018 | Outlook Therapeutics, Inc. | ONS | Other (acquisition) | Series A-1 Convertible Preferred Stock | 1.5k | $0.00 | $0 | | 12/31/2018 |
12/03/2018 | Outlook Therapeutics, Inc. | ONS | Grant | Common Stock | 4.3M | $0.93 | $4M | | 12/03/2018 |
11/07/2018 | Outlook Therapeutics, Inc. | ONS | Grant | Common Stock | 8.6M | $0.93 | $8M | | 11/07/2018 |
09/30/2018 | Outlook Therapeutics, Inc. | ONS | Other (acquisition) | Series A-1 Convertible Preferred Stock | 1.6k | $0.00 | $0 | | 09/30/2018 |
09/30/2018 | Outlook Therapeutics, Inc. | ONS | Other (acquisition) | Series A-1 Convertible Preferred Stock | 1.5k | $0.00 | $0 | | 09/30/2018 |
07/18/2018 | Outlook Therapeutics, Inc. | ONS | Grant | Series A-1 Convertible Preferred Stock | 58.7k | $0.00 | $0 | | 07/18/2018 |
07/18/2018 | Outlook Therapeutics, Inc. | ONS | Grant | Series A Convertible Preferred Stock | 6.5k | $0.00 | $0 | | 07/18/2018 |
07/18/2018 | Outlook Therapeutics, Inc. | ONS | Disposition | Series A Convertible Preferred Stock | 58.7k | $0.00 | $0 | | 07/18/2018 |
06/20/2018 | Outlook Therapeutics, Inc. | ONS | Conversion | Common Stock | 31.6M | $0.00 | $0 | | 12/31/2017 |
06/20/2018 | Outlook Therapeutics, Inc. | ONS | Conversion | Series A Convertible Preferred Stock | 208.8k | $0.00 | $0 | | 12/31/2017 |
06/08/2018 | Outlook Therapeutics, Inc. | ONS | Grant | Warrants | 10.3M | $0.98 | $10M | | 12/31/2017 |
06/08/2018 | Outlook Therapeutics, Inc. | ONS | Grant | Common Stock | 6.4M | $0.98 | $6.2M | | 12/31/2017 |
05/14/2018 | Outlook Therapeutics, Inc. | ONS | Grant | Warrants | 10.3M | $0.98 | $10M | | 12/31/2017 |
05/14/2018 | Outlook Therapeutics, Inc. | ONS | Grant | Common Stock | 6.4M | $0.98 | $6.2M | | 12/31/2017 |
|